A RECOMBINANT PLATFORM FOR PRIORITIZING AEROLYSIN MOLECULAR GRENADES FOR METASTATIC PROSTATE CANCER

$118,254FY2014Department of the ArmyDOD

The Johns Hopkins University

Investigators